Acorda Therapeutics Inc (NASDAQ:ACOR)

26.40
Delayed Data
As of Feb 22
 +0.30 / +1.15%
Today’s Change
13.60
Today|||52-Week Range
33.00
+23.08%
Year-to-Date

Today’s Trading

Previous close26.10
Today’s open26.30
Day’s range26.00 - 26.75
Volume518,680
Average volume (3 months)773,871
Market cap$1.2B
Data as of 4:00pm ET, 02/22/2018

Growth & Valuation

Earnings growth (last year)-539.47%
Earnings growth (this year)--
Earnings growth (next 5 years)+29.00%
Revenue growth (last year)+13.22%
P/E ratioNM
Price/Sales1.68
Price/Book--

Competitors

 Today’s
change
Today’s
% change
OMEROmeros Corp-1.56-14.77%
ATNXAthenex Inc+0.04+0.25%
DERMDermira Inc+0.05+0.19%
CLLSCellectis SA+0.05+0.15%
Data as of 4:00pm ET, 02/22/2018

Financials

Next reporting dateApril 26, 2018
EPS forecast (this quarter)$0.94
Annual revenue (last year)$588.3M
Annual profit (last year)-$223.4M
Net profit margin-37.97%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Ronald Cohen
Chief Scientific Officer
Andrew R. Blight
Corporate headquarters
Ardsley, New York

Forecasts